(Q33402808)

26 July 2017

title

Hemolytic-uremic syndrome, malignant hypertension and IgA nephropathy: successful treatment with plasma exchange therapy (English)

1 reference

hemolytic-uremic syndrome

26 July 2017

main subject

1 reference

based on heuristic

inferred from title

malignant hypertension

1 reference

Chrysoula Pipili

1

1 reference

26 July 2017

Konstantinos Pantelias

2

1 reference

26 July 2017

Nikos Papaioannou

3

1 reference

26 July 2017

Helen Paraskevakou

4

1 reference

26 July 2017

Eirini Grapsa

5

1 reference

26 July 2017

language of work or name

1 reference

11 August 2012

1 reference

Transfusion and Apheresis Science

26 July 2017

published in

1 reference

26 July 2017

volume

47

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

155-158

1 reference

A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Thrombotic microangiopathy: new insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Atypical hemolytic uremic syndrome: update on the complement system and what is new.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Clinical practice. Today's understanding of the haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Immunoglobulin A nephropathy in China: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Primary antiphospholipid antibody syndrome and mesangial IgA glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Secondary IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Pathogenesis of thrombotic microangiopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Hemolytic uremic syndrome associated with immunoglobulin A nephropathy: a case report and review of cases of hemolytic uremic syndrome with glomerular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Clinicopathologic correlation in IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Incidence of latent mesangial IgA deposition in renal allograft donors in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Malignant hypertension in patients with idiopathic IgA nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Hemolytic uremic syndrome: pathogenesis and update of interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Recommendations for the use of therapeutic plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Plasma therapies in thrombotic syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

Hemolytic Uremic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.06.018

10.1016/J.TRANSCI.2012.06.018

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference